Algae Extract

We rate Algae Extract Caution at Low confidence, and we want to be exact about why: acne estheticians who see clogged skin every day put it on their avoid-lists, but no assay, no study and no stated method stands behind that — and the label itself names an entire category of organisms rather than an ingredient.

Caution Low confidence No legacy score. It does not appear in the assay corpus we searched.

Cautioned by acne clinics on no published basis. The INCI label was retired in 2015.

Sources disagree: This rating rests on an uncited commercial avoid-list, and we would rather say so than dress it up. No assay, no study, no stated method supports it. The mechanism usually offered — iodine — is contradicted by its own primary source. We keep the Caution because clinicians who see acne patients daily report it, and that is worth something; we hold the confidence at Low because reporting is not measuring.

What it is

Not a substance. A label. "Algae Extract" is an INCI name that was originally published in 1979 and given retired status in 2015 — a naming category so broad that regulators stopped accepting it. It meant, literally, the extract of unspecified species of algae. The European Commission now requires the genus and the species, so a product formulated today should say Laminaria Digitata Extract or Chlorella Vulgaris Extract, though for an interim period trade names filed under the old label were allowed to keep it. The Cosmetic Ingredient Review's own chemistry section puts the problem more bluntly than any critic could: "Algae" is not a taxonomic group, but a functional group of convenience. Some algae are seaweed, some are protozoa, and some belong in other kingdoms altogether. Spirulina, which appears on the same clinic avoid-lists as kelp, is a cyanobacterium — a bacterium. The CIR has assessed 82 brown algae-derived and 60 red algae-derived INCI names — the names as they appear on a label, which is not the same count as distinct materials, since several resolve to the same substance. In a formula, what these extracts actually do varies as widely as what they are: most are logged as skin-conditioning agents, and the algae-derived polysaccharides — algin from brown algae, carrageenan from red — are thickeners and gelling agents. Two products both listing "Algae Extract" do not share a mechanism, because they do not share anything.

Why we rate it Caution

We rate it Caution at Low confidence, on an evidence tier we call uncited-list — and that tier exists because of this ingredient. This page is worth starting with the correction rather than hiding it at the bottom. Until this entry was researched, algae extract was filed in our data as evidence_tier "consensus", which pays out Moderate confidence and reads, fairly, as "dermatologists agree." It also cited acne.org. Neither was true. acne.org's compiled list of 45 comedogenic ingredients — drawn from eleven published rabbit-ear and human studies spanning 1968 to 2009 — contains no algae-derived ingredient at all, so that citation did not support the rating it was cited for, and it has been removed. What remained was a single uncited esthetician avoid-list, and our own taxonomy had no slot for that; the closest available label, "consensus," was an overclaim, committed by our own schema. So we added a fourth tier. uncited-list says the plain thing — somebody asserted it and showed no work — and it pays out Low. It is described on /how-we-decide, and algae extract is the reason it is there. What actually stands behind the rating is this: the pore-clogging ingredient lists used by acne-focused estheticians. Face Reality's list, which our data cites, includes Algae Extract, Algin, Carrageenan, Chondrus Crispus, Chlorella, Spirulina, Red Algae, Seaweed and Plankton. It is an alphabetical list of names on a brand's own site, published without a citation, a method, a number, or a reference to any study, alongside products sold as free of the ingredients on it. That is an opinion with a commercial interest attached, and it should be read as one. Now the mechanism — and we have to correct ourselves again before we can even use it. We wrote that "the mechanism those lists offer is iodine." The list we cite offers no mechanism at all. It is roughly eighty ingredient names in two columns, and it gives no reason for a single one of them. The iodine story circulates in the wider acne-list culture; we could not find it stated on the document we actually cite, and we should not have told you it was there. The story is still worth answering, because you will meet it: algae is iodine-rich, iodine is excreted through the follicle, and this provokes comedones. It does not hold up. But it is worth being exact about why, because a lazy dismissal would be nearly as bad as the claim. Iodine-induced eruption is real, and here is the strongest version of the lists' case, stated before we take it apart: iododerma most commonly presents as an ACNEIFORM eruption, and its lesions localise to the regions of skin with the highest sebaceous-gland density. It looks like acne, in the places acne appears. But it is not a comedone. Under the microscope it is a neutrophilic hypersensitivity reaction — ulceration, neutrophils, histiocytes, fibrinoid necrosis — and not a plugged follicle. And the exposures that produce it are systemic and substantial: iodinated radiographic contrast, potassium iodide, amiodarone, expectorants, and on the topical side povidone-iodine antiseptic and iodoform gauze, which is iodine applied to broken skin as a drug. It falls disproportionately on people whose kidneys cannot clear iodine. We also put a number on the threshold — "therapeutic doses of potassium iodide in the range of 4 to 6 grams a day" — and that number was not ours to give. No source we cited supports it. Worse, the literature does not support a threshold at all: the case literature describes the mechanism as the accumulation of iodine to a critical level that the case literature has never quantified, and states plainly that the pathophysiology remains unknown. We invented a figure that made the danger sound comfortably far from any cosmetic exposure. It flattered our own conclusion, which is exactly why we should have checked it and did not. The conclusion survives without it, on better ground. The wrong lesion is the wrong lesion at any dose. And on the dose question the CIR panel ran the arithmetic itself and rejected the mechanism in its own words: systemic exposure to iodine from the use of brown algae ingredients in cosmetics would be far less than that resulting from ingestion. As for the paper the iodine idea is usually traced to — Hitch and Greenburg's 1961 questionnaire study of North Carolina adolescents — it concluded that reasonable amounts of ingested iodine are not significant to the prevalence or severity of adolescent acne, and found the lowest acne rates among the teenagers eating the most seafood. The paper most often invoked for the mechanism is a paper that argues against it. So why keep the Caution at all? Here we have to be careful, because our first answer to that question was itself invented. We wrote that the Caution rested on "chair-side observation across thousands of faces." There is no such observation. The source is an alphabetical avoid-list on an acne clinic's website. It contains no patient count, no case series, no before-and-after, no comedone counts, no protocol — nothing but names. We had taken a list and imagined a clinic behind it, complete with a number, which is a tidier and more literary version of exactly the thing this site exists to object to. So the honest answer is thinner and we are going to leave it thin. The Caution is a precaution. It exists because practitioners who treat acne put this ingredient on an avoid-list, and we are not in the business of dismissing people who see skin every day merely because they did not publish. But an unpublished opinion is an opinion. We cannot tell you how many faces it rests on, because we do not know, and neither does anyone else who repeats it. The confidence is Low, the tier is literally called `uncited-list`, and this paragraph is what that tier means.

What the evidence doesn’t tell you

Nobody we can find has measured this, and we want to be precise about the shape of that absence rather than overclaim it in the other direction. What we can say is what we checked: there is no rabbit-ear score for algae extract in Fulton's table or in any legacy assay we hold; the CIR's brown and red algae safety reviews contain no comedogenicity endpoint; the 2021 systematic review of the human clinical literature on topical macroalgae contains none either; and acne.org's compilation of published comedogenicity testing contains no algae-derived ingredient at all. That is the boundary of what we looked at. It is not proof that no obscure, proprietary, non-English or unpublished assay has ever existed anywhere — we have not audited every microalgal and cyanobacterial ingredient on earth, and we are not going to pretend a search is a census. The 2021 systematic review of macroalgae in cosmeceuticals in the Journal of Clinical and Aesthetic Dermatology found eight human studies of topical seaweed extracts, and not one of them measured comedogenicity — the word does not appear in the paper. Neither does it appear anywhere in the CIR's safety assessments of the brown or red algae-derived ingredients, which run to hundreds of pages of submitted industry data on irritation, sensitisation and impurities. Comedogenicity was simply never on the agenda. Absence of a test is not a clean bill. But we also have to correct what we said about those reviews. We wrote that the CIR found "only 6 of 82" brown algae ingredients safe as used — a figure suggesting a field almost entirely unassessed. That number came from a MARCH 2019 DRAFT stamped "Distributed for Comment Only — Do Not Cite or Quote", which warned on its face that the count might change. It did. The final report, published in October 2019, concludes that 68 OF THE 82 brown algae-derived ingredients are safe as used, with insufficient data on the remaining 14. We had quoted a provisional number from a document that told us not to quote it, and it pointed the opposite way from the truth. None of which is comedogenicity evidence either way — the final report mentions acne once, in passing, and never measures a pore. "We know very little about this ingredient" and "we know very little about what this ingredient does to a pore" are two different sentences. We ran them together. Only the second one is true. The deeper limit is the one the rating cannot escape. A comedogenic rating is a claim about a molecule's behaviour in a follicle, and "algae extract" is not a molecule — it is a retired label covering organisms from a freshwater bacterium to a thirty-metre kelp, whose composition, as the CIR notes, varies with species, season, age, harvest and extraction method. Whatever is true of Ascophyllum nodosum in a mask at 3% need not be true of Chlorella in a serum at 0.1%, and we can find no study showing it is true of either. A single comedogenic verdict spanning several biological kingdoms is close to meaningless, and we would rather print that sentence than pretend the rating is more precise than the label it is attached to. This is a case where the honest answer is that the question, as posed, does not have one — and where a reader reacting to the word "algae" on a label is reacting to a word, not to a measured risk.

Where you’ll see it

Marine and "blue beauty" moisturisers, sheet masks, eye creams, hydrating serums, and body firming products, where algae tends to function as a positioning device as much as an ingredient. Those are illustrative categories, not a measured prevalence: we have not audited the market, and we are not going to put a number on it that we did not count. The same caution applies to where it sits on a label. Position is not a dose, we cannot read one off the other, and neither can anyone else. It appears as Algae Extract on older labels and increasingly under species names — Laminaria, Ascophyllum Nodosum, Chondrus Crispus, Chlorella Vulgaris, Spirulina Platensis, Undaria Pinnatifida. Its family siblings are met more often as functional ingredients than as actives: Algin and Carrageenan are thickeners and gelling agents. We previously said both "carry legacy scores that algae extract itself does not." They do not. Neither appears in Fulton's table or in any of the legacy numeric assays; both sit on the same uncited clinic avoid-list, exactly as algae extract does. Our own provenance file records both as untraceable, and the page said otherwise. Promoting a consumer-list entry into a "legacy score" is the precise error this site was built to name.

Sources

Each source says what it actually is. Several widely-cited “sources” for comedogenic ratings are republishing the same 1989 assay, and counting them as independent agreement is how a thin evidence base gets made to look thick.

  1. Face Reality Skincare pore-clogging ingredient list The entire basis of this rating, and not a study. An uncited alphabetical list of ingredient names — Algae Extract, Algin, Carrageenan, Chlorella, Spirulina, Seaweed, Plankton — published on the site of a brand that sells products formulated without them. No method, no scores, no references, no patients. We previously wrote that it "may well encode real chair-side observation from practitioners who see clogged skin every day" — which sounds fair-minded and is pure invention. The list provides no case series, no counts, no protocol, and no exposure data. The list is published by an acne clinic. That tells you WHO WROTE IT. It does not tell you what they measured, and the answer, as far as anything public shows, is nothing. It also has a commercial interest attached: the brand sells products formulated without the ingredients on it. This source is why the `uncited-list` evidence tier exists: it is the only thing holding the rating up, and calling it "consensus" would have been a lie about our own confidence.
  2. Hitch JM, Greenburg BG. "Adolescent acne and dietary iodine." Arch Dermatol 84:898–911 (1961) The most-cited primary source for the idea that iodine causes acne — and cited here because it does not support it: the authors concluded that reasonable amounts of ingested iodine are not significant to the prevalence or severity of adolescent acne, and observed the lowest acne rates in the adolescents eating the most fish and seafood. It is also a dietary questionnaire study, not a study of anything applied to skin. One correction to our own framing: we previously called this "the primary study underneath the iodine-causes-acne claim that the clinic lists use," which asserts a provenance we cannot show. The list we cite states no mechanism at all and cites nothing. We can say this paper is where the iodine idea is usually traced. We cannot say the lists are tracing it. (The surname is printed Greenburg here and appears as Greenberg elsewhere; we cite it as printed.)
  3. Hesseler MJ et al. "An acneiform eruption secondary to iododerma." JAAD Case Reports 4(5):468–470 (2018). PMID 29984285 The primary document behind the iodine paragraph, read in full rather than summarised from a list. It is cited BOTH WAYS, which is the point. Against us: it confirms that iododerma most commonly presents as an acneiform eruption and that its lesions localise to skin with high sebaceous-gland density — the strongest form of the case the avoid-lists are gesturing at. For us: the biopsy shows an ulcer with neutrophils, histiocytes and fibrinoid necrosis, which is a hypersensitivity reaction and not a comedone; the documented routes are systemic and substantial (iodinated contrast, potassium iodide, amiodarone, expectorants) or topical as a wound antiseptic (povidone-iodine, iodoform gauze); and it falls disproportionately on people with impaired renal clearance. It also says the pathophysiology is unknown and describes the requirement only as "accumulation of the offending agent to a critical level" — no number. That absence is why our "4 to 6 grams a day" had to come out: we had quantified a threshold the literature declines to quantify, in the direction that suited us.
  4. Cosmetic Ingredient Review. "Safety Assessment of Brown Algae-Derived Ingredients as Used in Cosmetics" — FINAL REPORT (October 2019) The final report, and we link it deliberately, because we got burned on this one. Source of the statement that "algae" is not a taxonomic group but a functional group of convenience; of the 82 brown-algae INCI names; of the conclusion that 68 of those 82 are safe as used with insufficient data on the remaining 14; and of the finding that systemic iodine exposure from cosmetic algae would be far below dietary exposure. We originally cited the MARCH 2019 draft instead — a document stamped "Distributed for Comment Only — Do Not Cite or Quote," carrying a provisional count that pointed the opposite way. Comedogenicity is not assessed anywhere in it, which is worth saying, because this is a document where a measurement would live if one existed.
  5. Cosmetic Ingredient Review. "Safety Assessment of Red Algae-Derived Ingredients as Used in Cosmetics" — FINAL REPORT (2021) The red-algae counterpart, linked separately rather than folded into the brown report, because they are two documents and citing two documents under one link is how a reader loses the ability to check us. Source of the 60 red-algae INCI names. Comedogenicity is not assessed here either.
  6. Almeida IF et al. "Marine Ingredients for Sensitive Skin: Market Overview." Mar Drugs 19(8):464 (2021) Peer-reviewed label audit of 88 sensitive-skin cosmetics. The source for the naming problem. Documents that the designation "algae extract" with no species specification was permitted in CosIng, that the Commission now requires the genus and species, and that the authors had to classify products carrying the old label as "undefined" because they could not determine what alga was in them. If researchers auditing labels cannot tell what the ingredient is, neither can a rating.
  7. Murphy MJ, Dow AA. "Clinical Studies of the Safety and Efficacy of Macroalgae Extracts in Cosmeceuticals." J Clin Aesthet Dermatol 14(10):37–41 (2021). PMID 34976289 Systematic review of the human clinical evidence for topical seaweed extracts. It identified eight human studies, all concerned with moisturisation, pigmentation or cellulite. None measured comedones; the word "comedogenic" does not appear in it. Cited as the boundary of the human evidence, not as reassurance — and with the disclosure that its second author is the founder of an algae-based skincare company, which is exactly the kind of interest we insist on naming in the lists that flag algae.
  8. acne.org comedogenic ingredient list Formerly cited in our data as a source for this rating. It was removed, because it does not support it. Its list of 45 comedogenic ingredients, compiled from eleven published rabbit-ear and human studies including Fulton 1984 and 1989, contains no algae-derived ingredient at all — not algae extract, not algin, not carrageenan, not kelp. It is cited here for the absence, which is the finding: the most complete catalogue of published comedogenicity testing has never tested this. A citation that does not contain the ingredient it is cited for is not a source, and we would rather show the correction than quietly delete it.

Others in the same family

Algae & seaweed behave similarly enough that the evidence for one is often wrongly read across to the others. These are its structural relatives, not a guess. What the evidence says about algae & seaweed as a family ›

Last reviewed 2026-06-23 · How we decide

‹ Check a full ingredient list